跳至主要内容
临床试验/CTRI/2019/08/020838
CTRI/2019/08/020838招募中2 期

â??A Randomized Standard Controlled Clinical Study to Compare the Safety and Efficacy of a Unani Formulation Safoof-e-Ziabetus Dulabi with Metformin in DhayÄ?bīṭus HÄ?rr Qism ThÄ?nÄ« (Type 2 Diabetes Mellitus)â?? - T2DM

Central Council for Research in Unani Medicine0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • i) Patients of any sex in the age group between 25 and 60 years
  • ii) Fasting Plasma Glucose levels between 126 and 175 mg/dL
  • Post pandrial Plasma Glucose levels between 200 and 250 mg/dL
  • (2 hours after ingestion of 75 gm of glucose in 300 ml of water)
  • iii)HbA1C level>=6.5 % and
  • iv) Presence of any of the following symptoms and signs of diabetes mellitus:
  • 2. Utash Mufrit(Polydipsia)
  • 3. Kasrat al-Bawl (Polyuria)
  • 4. Kasrat al-Ishtiha (Polyphagia)
  • 5. Bawl Layli (Nocturia)
  • 6. Iâ??ya(Fatigue)
  • 7. Naqs al-Wazn (Loss of Weight)
  • 8. Sozish-e-Kaf-e-Dast-o-Pa (Burning sensation in palm and soles)
  • 9. Sadr (Giddiness)
  • 10. Naqs al-Shahwa (Loss of Libido

排除标准

  • Any of the following:
  • 1.Subjects with fasting plasma glucose level >175 mg/dl and /or
  • 2.Post-pandrial plasma glucose level >250 mg/dl
  • 3.Subjects on Insulin therapy
  • 4.Diabetes Mellitus-Type I
  • 5.Secondary Diabetes Mellitus
  • 6.Diabetes Mellitus associated with complications of Ketoacidosis.
  • 7.Ischemic Heart Disease/ Hypertension/ Hyperlipidemia
  • 8.Liver disorders
  • 9.Impaired Renal function tests
  • 10.Obese Subjects â?? BMI >30
  • 11.Pregnant and lactating women
  • 12.Any infective disorder requiring long-term treatment
  • 13.Drug addicts/ Alcoholics
  • 14.Malignancy/ Epilepsy

研究者

相似试验